This product is a β-lactamase-stable cephalosporin bactericidal antibiotic that works by blocking the synthesis of the main cell wall polymer - peptidoglycan. It can quickly penetrate the bacterial cell wall and bind to the target enzyme (penicillin binding protein) with high affinity. It has a bactericidal effect on a fairly broad spectrum of Gram-negative and Gram-positive pathogens at low concentrations.

Pharmacological action not specified

No specific description provided

Cefepime is a broad-spectrum fourth-generation cephalosporin that achieves bactericidal effects by inhibiting the biosynthesis of bacterial cell walls. It is effective against both gram-positive and gram-negative bacteria, is highly resistant to hydrolysis by most beta-lactamases, and can quickly penetrate into the cells of gram-negative bacteria. Its target molecule is penicillin-binding protein (PBP). In vitro and clinical studies have confirmed that this product is active against a variety of microorganisms, including but not limited to Enterobacter, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus (methicillin-sensitive strains only), Streptococcus pyogenes, Streptococcus pneumoniae, etc.